Omzo vs HumeCare+: Compounded GLP-1, Price and Support Compared
Quick verdict: Omzo vs HumeCare+
Omzo and HumeCare+ both offer clinician-prescribed compounded GLP-1 treatment, but they target different priorities: Omzo emphasizes clinician-guided, personalized compounded semaglutide and tirzepatide with a starting price of $179, while HumeCare+ sells a bundled protocol with added glycine and B vitamins, body-composition scans, and semaglutide starting at $199 per month. Early verdict: choose Omzo for lower starting pricing and basic clinician-guided compounded options; choose HumeCare+ if you want a protocol that explicitly focuses on muscle preservation, tracking, and 24/7 clinician access.
How these services differ at a glance
Both providers offer clinician-determined prescriptions for GLP-1 medications, including compounded semaglutide and tirzepatide when available. Key distinctions come from price structure, added supportive ingredients and services, refund promises, and delivery or support features. The comparison below uses only the supplied facts and preserves each qualifier exactly.
Most distinctive differences
- Pricing and billing cadence: Omzo lists semaglutide starting at $179 and tirzepatide starting at $279; HumeCare+ lists semaglutide from $199 per month and tirzepatide plus B12 and glycine from $299 per month.
- Supportive protocol vs bare medication: HumeCare+ bundles glycine, B12, and B6 into its protocol and offers body-composition scans and an app; Omzo emphasizes clinician-guided plans and offers compounded medications or prescriptions for branded medicines without an included supportive protocol.
- Outcome promise and tracking: HumeCare+ advertises a 10%-or-your-money-back promise over six months and monthly body-composition scans; Omzo does not advertise a money-back promise in the supplied evidence.
- Compounded medication status: Both offer compounded medications; both notes that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo explicitly states its compounded drugs are not FDA-approved and that providers may instead write prescriptions for branded medications.
- Accessibility and care model: Omzo connects users to licensed U.S. providers through its platform; HumeCare+ emphasizes continuous physician optimization, unlimited clinician access, and a 24/7 U.S. care team in the supplied evidence.
Direct comparison table
| Criterion | Omzo | HumeCare+ |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Semaglutide from $199/month; tirzepatide + B12 + glycine from $299/month |
| Medication type | Personalized compounded semaglutide and tirzepatide; providers may prescribe branded meds | Physician-prescribed compounded semaglutide or tirzepatide with glycine and vitamins built into the formulation |
| Support services | Clinician-guided plans reviewed by licensed U.S. providers | Body-composition scans, app, unlimited clinician access, 24/7 U.S. care team |
| Guarantee or refund | Not supplied in the evidence | 10%-or-your-money-back promise over six months (terms apply) |
| Delivery and cancellations | Fast, discreet delivery; FSA & HSA eligible noted | Free next-day delivery; cancel subscription anytime |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not evaluated by the FDA for safety, quality, or efficacy |
Pricing and what you get for the money
Omzo lists a lower entry price for semaglutide at $179 and positions its platform as clinician-guided with compounded medication options produced by state-licensed sterile compounding pharmacies. HumeCare+ lists semaglutide from $199 per month and positions its plans as bundled protocols that include glycine and B vitamins, monthly body-composition scans, and an app. HumeCare+ also advertises a 10% weight-loss promise over six months with refund terms to verify before enrolling. Both providers note that compounded medications are not FDA-approved and that availability and terms may change.
See HumeCare+ protocol details
Clinical oversight, tracking and added ingredients
Omzo connects people with licensed U.S. providers who determine eligibility and prescribe either compounded medications or, alternatively, prescribe branded FDA-approved medications for patients to fill elsewhere. HumeCare+ explicitly packages clinician-prescribed GLP-1 medication with glycine, B12, and B6 in its formulation for muscle support and side-effect relief, and it tracks lean mass through body-composition scans. If monitoring lean mass and an integrated app are important to you, HumeCare+ supplies those features; if you prefer a clinician-guided prescription option with potential access to branded medications via a provider, that is how Omzo describes its service.
Safety, regulatory and outcome claims
Both providers include the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Omzo explicitly states compounded drugs are not FDA-approved and that providers make the final determination on prescriptions. HumeCare+ cites internal company-reported figures and positions its program with internal analysis and a money-back promise; it also notes that headlines and results are internal and that individual results may vary.
Final comparison and how to choose
Omzo vs HumeCare+ comes down to cost and program scope. Omzo is focused on clinician-guided compounded semaglutide and tirzepatide with a lower listed starting price and the option for providers to prescribe branded medications to be filled elsewhere. HumeCare+ wraps GLP-1 medication into a bundled protocol that adds glycine and B vitamins, monthly body-composition scans, an app, unlimited clinician access, free next-day delivery, and a 10%-or-your-money-back promise over six months with terms to verify.
Choose Omzo if…
- You prioritize a lower starting price for compounded semaglutide or access to clinician-guided options and potential prescriptions for branded medications. Confirm eligibility, total cost, renewal terms and state availability before enrollment, as Omzo advises.
Choose HumeCare+ if…
- You want a bundled GLP-1 protocol that includes glycine and B vitamins, monthly body-composition scans, an app, and continuous clinician access, and you value HumeCare+ advertized tracking and its 10%-or-your-money-back promise subject to terms.
Both platforms require a clinician to determine medical appropriateness and both note that compounded medications are not FDA-approved. Verify full terms, eligibility and documentation directly with each provider before enrolling.